
REALSEQ BIOSCIENCES, INC.
Realizing RNA Fragmentomics
Santa Cruz, United States · Founded 2018 · $1.5M raised
- Headquarters
- Santa Cruz, California
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- realseq.com
- Total Funding
- $1.5M
- Last Round
- $1.5M SeedMar 2024
- Rounds
- 1
About
RealSeq Biosciences develops the RiboMarker RNA fragmentomics platform to enable next-generation cell-free RNA diagnostics. Founded in 2019 by scientists from UC Santa Cruz, the company is built on NIH Phase I and II grant funding and focuses on detecting small RNA fragments too difficult to analyze with existing tools. Its initial applications target fungal pathogen diagnostics including Valley Fever.
Summary
REALSEQ BIOSCIENCES, INC. is a Biotech company based in Santa Cruz, United States, founded in 2018. It has raised $1.5M in total across 1 round, most recently a $1.5M Seed round in Mar 2024. Investors include Charleston Angel Partners.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2024
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...